StocksU › UNH

UnitedHealth Group Incorporated (UNH) — Earnings Call X-Ray

Our AI read all 38 of UNH's earnings calls (2016–2025) and answered the same battery of questions about each one. Every past call is free; the newest quarter unlocks with a free account.

Latest Call Grade
🔒
Q1 2025 · sign up to see
Previous Call Grade
C+
Q4 2024
Expected Move
🔒
next 45 days · members
Calls Analyzed
38
2016–2025
Avg Candor
6.6/9
evasion 3.3/9
High CandorSkeptic ReassuredCritic AmmunitionRaising PricesMargins ContractingBacklog GrowingCapex IncreasingReads Rehearsed

Call-by-call analysis

🔒 Q1 2025 earnings call 2025-04-17 NEWEST

Guidance: ■■■■■Demand: ■■■■■■ Margins: ■■■■Backlog: ■■■■ ■ analysts, ■■ questionsexpected move ±■■%
Candor /9
Specificity /9
Evasion /9
Stress /9

Management ■■■■■■ guidance against ■■■■■■■■ demand and ■■■■■■■ margins. The delivery was ■■■■■■■■ and ■■■■ in specifics, with ■■■ questions left hanging.

🔒 The Q1 2025 call grade is ready
The full 37-point AI read of UNH's newest earnings call — grade, expected move, and every question answered — is free with an account.
Sign up free to unlock

C+ Q4 2024 earnings call 2025-01-16 move ±8.1%

Management held guidance steady against steady demand and contracting margins. The delivery was unusually candid, rich in specifics.

Guidance: maintainedDemand: stableMargins: contractingBacklog: growingPricing: raisingCapex: increasing 10 analysts · 11 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts⚑ Reads rehearsedDirection beats results
Candor 7/9
Specificity 8/9
Evasion 3/9
Confidence 8/9
Uncertainty 2/9
Promotion 5/9
Stress 4/9
Complexity 8/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

D Q3 2024 earnings call 2024-10-15 move ±9.9%

Management held guidance steady against steady demand and contracting margins. The delivery was unusually candid, rich in specifics.

Guidance: maintainedDemand: stableMargins: contractingBacklog: growingPricing: under pressureCapex: increasing 11 analysts · 11 questions
⚑ Critic ammunition⚑ Question left hanging✓ Guidance underwritable⚑ Reads rehearsed
Candor 7/9
Specificity 8/9
Evasion 3/9
Confidence 6/9
Uncertainty 5/9
Promotion 5/9
Stress 4/9
Complexity 7/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

C Q2 2024 earnings call 2024-07-16 move ±11.6%

Management held guidance steady against steady demand and contracting margins. The delivery was rich in specifics.

Guidance: maintainedDemand: stableMargins: contractingBacklog: growingPricing: under pressureHeadcount: flat 11 analysts · 14 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts⚑ Reads rehearsed
Candor 6/9
Specificity 8/9
Evasion 4/9
Confidence 8/9
Uncertainty 3/9
Promotion 5/9
Stress 3/9
Complexity 7/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

C+ Q1 2024 earnings call 2024-04-16 move ±9.5%

Management held guidance steady against steady demand. The delivery was unusually candid, rich in specifics.

Guidance: maintainedDemand: stableMargins: stableBacklog: growingPricing: under pressure 15 analysts · 15 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts
Candor 7/9
Specificity 8/9
Evasion 2/9
Confidence 8/9
Uncertainty 4/9
Promotion 5/9
Stress 3/9
Complexity 6/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

C+ Q4 2023 earnings call 2024-01-12 move ±6.8%

Management held guidance steady against steady demand. The delivery was rich in specifics.

Guidance: maintainedDemand: stableMargins: stableBacklog: growingPricing: raising 11 analysts · 11 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts✓ Early product, fast growth⚑ Reads rehearsed
Candor 6/9
Specificity 8/9
Evasion 3/9
Confidence 8/9
Uncertainty 3/9
Promotion 5/9
Stress 3/9
Complexity 7/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

B Q3 2023 earnings call 2023-10-13 move ±6.5%

Management raised guidance against accelerating demand and contracting margins. The delivery was rich in specifics.

Guidance: raisedDemand: acceleratingMargins: contractingBacklog: growingPricing: under pressureCapex: increasing 13 analysts · 13 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts✓ Volume step-up ahead✓ Early product, fast growth
Candor 6/9
Specificity 8/9
Evasion 3/9
Confidence 8/9
Uncertainty 3/9
Promotion 5/9
Stress 2/9
Complexity 7/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
YES Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
YES Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

B+ Q2 2023 earnings call 2023-07-14 move ±9%

Management raised guidance against accelerating demand and contracting margins. The delivery was unusually candid, rich in specifics.

Guidance: raisedDemand: acceleratingMargins: contractingBacklog: growingPricing: raisingHeadcount: growing 10 analysts · 10 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubtsDirection beats results
Candor 7/9
Specificity 8/9
Evasion 2/9
Confidence 8/9
Uncertainty 3/9
Promotion 5/9
Stress 2/9
Complexity 6/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
YES Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

Earlier calls

CallDateGradeGuidanceDemandMarginsCandorEvasion
Q1 2023 2023-04-14 B raisedacceleratingstable 6/9 3/9
Q4 2022 2023-01-13 C maintainedacceleratingstable 6/9 4/9
Q3 2022 2022-10-14 A raisedstablecontracting 7/9 2/9
Q2 2022 2022-07-15 B raisedacceleratingstable 6/9 3/9
Q1 2022 2022-04-14 B raisedstableexpanding 6/9 3/9
Q4 2021 2022-01-19 B+ maintainedacceleratingstable 7/9 3/9
Q3 2021 2021-10-14 C+ raisedacceleratingstable 6/9 4/9
Q2 2021 2021-07-15 B raisedacceleratingexpanding 6/9 4/9
Q1 2021 2021-04-15 B+ raisedstableexpanding 7/9 2/9
Q4 2020 2021-01-20 B maintainedmixedunclear 7/9 2/9
Q3 2020 2020-10-14 D loweredmixedcontracting 6/9 4/9
Q2 2020 2020-07-15 D maintainedmixedcontracting 6/9 5/9
Q1 2020 2020-04-15 F maintainedmixedunclear 6/9 7/9
Q4 2019 2020-01-15 C+ maintainedacceleratingexpanding 7/9 3/9
Q3 2019 2019-10-15 B+ raisedacceleratingexpanding 7/9 3/9
Q2 2019 2019-07-18 B raisedstableexpanding 6/9 4/9
Q1 2019 2019-04-16 B+ raisedacceleratingexpanding 7/9 2/9
Q4 2018 2019-01-15 C+ maintainedacceleratingstable 7/9 2/9
Q3 2018 2018-10-16 B+ raisedacceleratingexpanding 6/9 3/9
Q2 2018 2018-07-17 B raisedacceleratingexpanding 6/9 3/9
Q1 2018 2018-04-17 B raisedacceleratingexpanding 6/9 4/9
Q4 2017 2018-01-16 A raisedacceleratingexpanding 7/9 3/9
Q3 2017 2017-10-17 B+ raisedacceleratingexpanding 7/9 3/9
Q2 2017 2017-07-18 C+ raisedacceleratingexpanding 6/9 5/9
Q1 2017 2017-04-18 B raisedacceleratingexpanding 6/9 4/9
Q4 2016 2017-01-17 C+ maintainedacceleratingexpanding 7/9 5/9
Q3 2016 2016-10-18 B+ raisedacceleratingexpanding 7/9 3/9
Q2 2016 2016-07-19 B+ raisedacceleratingcontracting 8/9 3/9
Q1 2016 2016-04-19 B+ raisedacceleratingstable 7/9 3/9
Q4 2015 2016-01-19 C+ maintainedacceleratingcontracting 7/9 3/9

Research question bank — earlier calls

During our 1,600-question research program, batches of experimental hypotheses were tested directly against some of UNH's earlier calls. The YES answers — the rare hits — are shown; click any question to see every company that matched it. Full list: the question bank.

B Q2 2022 earnings call 2022-07-15

1 more research questions answered NO

B+ Q4 2021 earnings call 2022-01-19

1 more research questions answered NO

A Q4 2017 earnings call 2018-01-16

276 more research questions answered NO

How to read this page

The grade is a transparent composite of call quality — candor, specificity, low evasion, low stress, whether the call resolves more doubts than it creates, and the guidance action — not a buy or sell signal. The expected move is a volatility estimate from the one signal that survived our out-of-sample tests: how a stock's own reaction and pre-call volatility predict the size (not direction) of its next move. Full detail, including everything that failed: methodology.

Companies with similar call quality

AA · Alcoa CorporationAAALF · Aareal Bank AGAABKF · Aareal Bank AGAAGIY · AIA Group LimitedAAL · American Airlines Group AAPL · Apple Inc.

UNFI   All “U” companies    UNIEF

Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.